摘要
目的分析益气活血通络汤联合阿司匹林治疗脑梗死的临床效果。方法90例脑梗死患者,按照奇偶法分为阿司匹林组和中西联合组,各45例。阿司匹林组采用阿司匹林治疗,中西联合组实施益气活血通络汤联合阿司匹林治疗。比较两组临床疗效和治疗前后中医证候积分。结果中西联合组治疗总有效率93.33%显著高于阿司匹林组的73.33%,差异具有统计学意义(P<0.05)。治疗前,两组中医证候积分比较差异无统计学意义(P>0.05);治疗后,两组中医证候积分均低于治疗前,且中西联合组中医证候积分(5.08±0.37)分低于阿司匹林组的(6.45±0.41)分,差异有统计学意义(P<0.05)。结论为脑梗死患者实施益气活血通络汤联合阿司匹林治疗的效果十分显著,可有效改善患者的中医证候,值得推广。
Objective To analyze the clinical effect of Yiqi Huoxue Tongluo Decoction combined with aspirin on cerebral infarction.Methods A total of 90 patients with cerebral infarction were divided into aspirin group and Chinese-Western combined group according to odd-even number method,with 45 cases in each group.Aspirin group was treated with aspirin,and Chinese-Western combined group was treated with Yiqi Huoxue Tongluo Decoction combined with aspirin.The clinical efficacy and traditional Chinese medicine syndrome score before and after treatment was compared between the two groups.Results The total effective rate 93.33%of Chinese-Western combined group was significantly higher than 73.33%of aspirin group,and the difference was statistically significant(P<0.05).Before treatment,there was no statistically significant difference in traditional Chinese medicine syndrome score between the two groups(P>0.05).After treatment,the traditional Chinese medicine syndrome score of the two groups was lower than that before treatment,and traditional Chinese medicine syndrome score(5.08±0.37)points of Chinese-Western combined group was lower than(6.45±0.41)points of aspirin group.All the difference was statistically significant(P<0.05).Conclusion Combination of Yiqi Huoxue Tongluo Decoction and aspirin shows remarkable effect on patients with cerebral infarction,and it can effectively improve the traditional Chinese medicine syndrome score of patients,which is worthy of promotion.
作者
李丽
LI Li(Anshan Hospital of Traditional Chinese Medicine,Anshan 114004,China)
出处
《中国现代药物应用》
2021年第8期195-197,共3页
Chinese Journal of Modern Drug Application
关键词
益气活血通络汤
阿司匹林
脑梗死
疗效
Yiqi Huoxue Tongluo Decoction
Aspirin
Cerebral infarction
Efficacy
